Initial Approach to Managing Thyroid Nodules
The initial approach to managing thyroid nodules should include thyroid ultrasound and TSH measurement, followed by fine-needle aspiration (FNA) of suspicious nodules based on size and ultrasound characteristics as the first diagnostic steps. 1, 2
Diagnostic Evaluation
Initial Assessment
- Thyroid ultrasound is essential as the first-line diagnostic procedure to detect and characterize thyroid nodules 2
- Serum TSH measurement should ideally be obtained before FNA, as higher TSH levels are associated with increased risk of differentiated thyroid cancer 1, 2
- Comprehensive neck ultrasound should evaluate nodule characteristics, cervical lymph node chains, and presence of extrathyroidal extension 2
Ultrasound Risk Stratification
- Based on ultrasound features, thyroid nodules can be categorized into low, intermediate, and high malignancy risk groups 3
- Suspicious ultrasound features that increase malignancy risk include:
Fine-Needle Aspiration (FNA) Indications
- FNA should be performed for nodules ≥1 cm in size 2, 3
- For nodules <1 cm, FNA should only be considered when suspicious ultrasound features are present 2, 3
- Nodules ≤5 mm should generally be monitored rather than biopsied 3
- Ultrasound-guided FNA is more accurate, economical, and safer than palpation-guided FNA 2
Clinical Risk Assessment
Clinical Features Increasing Malignancy Suspicion
- Nodules that are very firm, fixed to adjacent structures, or rapidly growing 1
- Presence of enlarged regional lymph nodes 1
- Vocal cord paralysis 1
- Symptoms of invasion into neck structures 1
- Family history of thyroid cancer 1
- Age <15 years and male gender 1
- History of head and neck irradiation 1
- Associated syndromes (familial adenomatous polyposis, Carney complex, Cowden's syndrome, MEN 2A or 2B) 1
Cytological Evaluation
FNA Cytology Classification
- Cytology results should be categorized according to the Bethesda System 2, 3:
- Nondiagnostic/unsatisfactory
- Benign
- Indeterminate (further subdivided into two categories)
- Suspicious for malignancy
- Malignant 1
Additional Testing
- Consider measuring serum calcitonin to rule out medullary thyroid cancer, which has higher sensitivity compared to FNA 2
- Molecular testing may be considered for indeterminate cytology results to improve management decisions 3, 5
Management Approach
For Benign Nodules
- Most thyroid nodules do not require treatment 3
- Levothyroxine suppressive therapy is not recommended 3
- Regular ultrasound surveillance is appropriate for benign cytology 2, 5
- Percutaneous ethanol injection (PEI) should be first-line treatment for relapsing benign cystic lesions 3
- Ultrasound-guided thermal ablation may be considered for symptomatic benign solid or mixed nodules 3
For Suspicious or Malignant Nodules
- Surgery remains the treatment of choice 3
- Total or near-total thyroidectomy is recommended for nodules ≥1 cm with confirmed malignancy 2
Common Pitfalls and Caveats
- A reassuring FNA should not override concerns when worrisome clinical findings are present, as false-negative results can occur 1, 2
- Overdiagnosis and overtreatment of small, subclinical nodules can lead to excessive costs and patient morbidity 5
- While more than 50% of malignant nodules are asymptomatic, the presence of suspicious clinical signs significantly increases malignancy risk 1
- Thyroid nodule evaluation should not follow a one-size-fits-all approach; risk stratification should guide the intensity of evaluation and follow-up 5, 6